PCT Bloodwork: The 6 Labs to Run Before and After Post-Cycle Therapy
PCT Bloodwork: The 6 Labs to Run Before and After Post-Cycle Therapy
PCT bloodwork is the only objective measure of whether the hormonal axis has recovered after a steroid cycle. Symptoms lag, overlap and lie; LH, FSH and testosterone do not. Two panels do the job: one drawn just before post-cycle therapy starts, to record how deep the suppression is, and one drawn 4 to 6 weeks after the last PCT dose, to show what the axis sustains on its own. This guide lists the six markers, the numbers that mean recovery, the numbers that mean a referral, and the mistakes that make the results unreadable.
Educational and harm-reduction content. MuscleScience does not sell or supply any compound and does not provide PCT protocols. Lab interpretation for an individual belongs with a clinician; non-medical anabolic steroid use is illegal in most countries.
PCT Bloodwork: 3 Things the Recovery Studies Show
Most PCT bloodwork advice is folklore. The recovery of the male axis after exogenous androgens has been measured directly, in contraceptive trials, in a prospective cohort of steroid users and in former users years later. Three findings set the frame for every panel below.
In the HAARLEM cohort (Smit 2021, 100 men followed through a self-chosen cycle), average total and free testosterone were back at baseline three months after the cycle ended, but total sperm count was still 61.7 million lower, and 29.7 million lower at the end of follow-up.
At the end of HAARLEM follow-up, 11 percent of men still had below-normal testosterone. Among former long-term users tested years later, 27 percent were below the reference limit (Rasmussen 2016), and 5 of 19 untreated former users were below 200 ng/dL after 3 to 26 months off (Kanayama 2015).
The pituitary signal recovers before the testes respond, and sperm recovers last: in pooled contraceptive data the median time for sperm to return to 20 million/mL was 3.4 months (Liu 2006). A panel without LH and FSH cannot tell a recovering axis from a stalled one.
The second panel is drawn after the PCT drugs have cleared, not during them. Clomiphene and tamoxifen raise LH and FSH pharmacologically for as long as they are taken; a panel drawn mid-PCT measures the drug, not the axis. Four to six weeks after the last dose is the earliest point at which the numbers mean what they appear to mean.
The two panels: what to draw before PCT starts and what to draw after it ends, with timing.
Six markers with numbers: testosterone, LH and FSH, estradiol, CBC, lipids and liver enzymes, and what each looks like when recovery is working or has stalled.
What the studies measured: HAARLEM, the contraceptive-trial pooled data and the former-user cohorts.
Five mistakes that turn a useful panel into noise, and when the right move is an endocrinologist rather than another round of PCT.
Why PCT Bloodwork Beats Symptoms
PCT bloodwork matters because suppression is not uniform. Sixteen weeks of testosterone enanthate at 500 mg a week shuts the axis down harder and longer than six weeks of an oral alone, and the difference decides how long recovery takes and whether PCT is doing anything. Symptoms cannot make that distinction. Low libido, fatigue, flat mood and weak morning erections correlate only loosely with the hormone level: one man is functional at 200 ng/dL and another is miserable at 280. Worse, the SERMs used in PCT act on mood and libido pathways of their own, so feeling better on clomiphene says nothing about whether LH has moved.
PCT bloodwork also has to be read in sequence, because the axis recovers in a fixed order. The hypothalamus and pituitary come back first, so LH and FSH rise; the Leydig cells respond over days to weeks, so testosterone follows; spermatogenesis, a 74-day process, comes last. That sequence is why a panel that includes gonadotropins is diagnostic and a panel that measures only testosterone is not. Testosterone at 320 ng/dL with LH at 3.2 IU/L is a recovering axis; 320 ng/dL with LH below 0.5 IU/L is a stalled one, and they need different responses. The mechanism is laid out in why steroids cause testosterone suppression and the timeline in hormonal recovery after steroids.
The same two panels also record the damage a cycle does outside the axis. HDL cholesterol falls on androgens, most sharply on oral 17-alpha-alkylated compounds (Baldo-Enzi 1990, Palatini 1996); hematocrit rises with testosterone dose; liver enzymes rise with orals. All of that should be trending back toward the pre-cycle baseline by the time the second panel is drawn, and if it is not, "recovered" is the wrong word whatever the testosterone says.
The 6 PCT Bloodwork Markers, Before and After
PCT bloodwork panel one is drawn after the esters have cleared and before the first PCT dose, ideally on the same day PCT starts or within two or three days before. Panel two is drawn 4 to 6 weeks after the last PCT dose. Status shows how much weight each marker carries in the recovery decision.
| Marker | Before PCT: expected | After PCT: recovery looks like | Status |
|---|---|---|---|
| Total testosterone | Low, often below 200 ng/dL after a heavy cycle, sometimes below 100. Confirms suppression; not alarming by itself. | Trending toward the pre-cycle baseline. Above roughly 400 ng/dL, with LH present, is a working recovery; below 300 at 4 to 6 weeks post-PCT means repeat, and below 264 (the harmonized lower limit, Travison 2017) at 3 to 4 months means referral. | ● Decisive |
| LH and FSH | Undetectable or near zero. This is the expected result of feedback suppression. | LH rising into the 3 to 8 IU/L range and FSH moving with it, with the drugs cleared. Rising gonadotropins with still-low testosterone is a positive trajectory; both still near zero is a stalled axis. | ● Decisive |
| Estradiol (LC-MS/MS) | Variable; can be high relative to the collapsed testosterone while aromatizable esters are still clearing, which itself suppresses LH. | Rising in proportion to testosterone; roughly 20 to 35 pg/mL alongside 400 to 600 ng/dL is a normal ratio. Disproportionately high E2 points to body fat or residual aromatization. | ● Context for the ratio |
| CBC: hematocrit, hemoglobin | Often elevated after injectable testosterone; 50 to 54 percent or higher is common at supraphysiological doses. | Falling as androgen stimulation stops. Above 50 percent post-PCT needs continued monitoring; above 54 percent is the threshold at which TRT guidelines act, and applies here too. | ● Safety |
| Lipid panel: HDL, LDL, triglycerides | HDL suppressed, most severely after stanozolol, oxandrolone or oxymetholone. | HDL rebounding; injectable-only cycles usually recover within 3 to 6 months, oral cycles more slowly. LDL and triglycerides recover faster than HDL. | ● Cardiovascular |
| Liver: ALT, AST, GGT | Elevated if 17-alpha-alkylated orals were used, sometimes two to five times the upper limit. | Trending to normal within 6 to 12 weeks of stopping the oral. AST also rises with training; GGT is the marker that separates liver from muscle. Persistently high GGT needs a workup beyond the cycle. | ● If orals were used |
Two additions to PCT bloodwork are worth the money when fertility matters: a semen analysis at the second panel, because HAARLEM shows sperm count lagging testosterone by months, and prolactin if LH stays low with a normal or low estradiol, because a pituitary problem masked during the cycle is one of the explanations for a stalled axis. Kidney markers belong on the panel for context; creatinine runs high in muscular men and the kidney markers guide explains how to read it. The individual markers are covered in hematocrit and hemoglobin, the lipid panel guide and liver markers.
PCT Bloodwork on Paper: What the HAARLEM Cohort Measured
The HAARLEM study is the closest thing to a controlled picture of what PCT bloodwork should show. One hundred men were tested before a self-chosen cycle, during it, three months after it ended and again at the end of the one-year study. Testosterone and sperm behaved very differently.
On average the PCT bloodwork picture was recovery: three months after the cycle, total and free testosterone were statistically indistinguishable from baseline, and they stayed there. Sperm did not. During the cycle 77 percent of men had a total sperm count below 40 million; three months after, the mean count was still 61.7 million below baseline, and at the end of follow-up it was still 29.7 million lower. That is the reason a testosterone result alone should never be read as "fully recovered" by a man who wants children, and why the second panel should include a semen analysis if that matters. The averages also hide the tail: 11 percent of men had below-normal testosterone at the end of follow-up.
A different view: the men who do not recover. Share of former or post-cycle users with low testosterone in three cohorts, versus controls.
Kanayama's untreated former users also averaged 131 ng/dL less testosterone than non-using weightlifters and had smaller testicular volume, and 29 percent of the whole former-user group had gone through a major depressive episode during withdrawal. Withdrawal hypogonadism is not rare, and it is not always temporary. The panel exists to catch it early, while it is still a bloodwork finding rather than a year of symptoms.
4 PCT Bloodwork Patterns and What Each One Means
PCT bloodwork recovery is a trajectory, not a threshold. The same testosterone number means different things depending on what the gonadotropins are doing beside it.
LH and FSH rising, testosterone still low: keep waiting
The pituitary has re-engaged and the Leydig cells are catching up. Testosterone typically follows within weeks. Repeat the panel in 4 to 6 weeks rather than adding drugs. This is the most common pattern at the first post-PCT draw and the one most often misread as failure.
Testosterone in range, LH and FSH present: recovered, on this marker
Compare against the pre-cycle baseline, not the lab range: a man whose natural level was 680 ng/dL is not recovered at 410, while a man whose baseline was 380 is. Then check the rest of the sheet. Hematocrit, HDL and, if fertility matters, sperm count can all still be abnormal on the day testosterone looks fine.
Testosterone low, LH and FSH near zero after the drugs have cleared: stalled axis
The signal is not coming back on its own. Possible reasons: PCT was too short for the depth of suppression, esters had not fully cleared when PCT started, or a pituitary or hypothalamic problem was masked during use. Recheck prolactin and estradiol and repeat once; if the picture holds at 3 to 4 months post-cycle, this is an endocrinology referral with the lab records in hand, not another self-managed round.
LH and FSH high, testosterone low: the testes are the problem
Gonadotropins above the normal range with persistently low testosterone means the pituitary is shouting and the testes are not answering. That is a primary pattern, seen after long or repeated cycles, and it does not respond to more SERM. It needs a clinician, and it is one of the routes by which cycle users end up on lifelong replacement, as described in TRT vs steroid cycles.
When to Draw PCT Bloodwork: The Schedule
PCT bloodwork timing rules follow from pharmacology. Long esters keep suppressing the axis for weeks after the last injection, and SERMs keep LH artificially high for as long as they are in the body. A panel drawn inside either window is a drug level, not a recovery level.
| Draw | When | What it answers | Status |
|---|---|---|---|
| Pre-cycle baseline | Before the first dose, ever | The only true reference point for every later panel; the lab range is a population average, the baseline is yours. See blood tests before steroids. | ● Minimum |
| Panel one: suppression | After ester clearance, on the day PCT starts or 2 to 3 days before | How deep the suppression is; the starting point for judging PCT. Timing of clearance by ester is in when to start PCT. | ● Minimum |
| Panel two: recovery | 4 to 6 weeks after the last PCT dose | What the axis sustains without pharmacological support: the recovery verdict. | ● Minimum |
| Panel three: confirmation | About 3 months post-cycle | Sustained recovery; normalization of hematocrit, HDL and liver enzymes; semen analysis if fertility matters (sperm lags by months). | ● Recommended |
| Monthly for 3 months | After long cycles, nandrolone or trenbolone, or deep suppression | Enough data points to see a trend and catch a stalled axis early. | ● Situational |
Draw every PCT bloodwork panel under the same conditions: morning, fasting, no training the day before, the same laboratory. The Endocrine Society's rule for diagnosing low testosterone, two separate morning samples, applies to the recovery question as well: a single low value can be illness, sleep loss or timing. Mid-cycle monitoring is a separate subject, covered in how often to get bloodwork on a cycle, and the full recovery timeline in the PCT recovery timeline.
PCT Bloodwork Does Not Measure Sperm
This is the gap PCT bloodwork cannot close. In the pooled contraceptive-trial data (Liu 2006, 1,549 men), the median time for sperm to recover to 20 million/mL after stopping testosterone was 3.4 months, and recovery was slower with longer treatment and longer-acting esters. HAARLEM found sperm count still depressed at the end of the one-year study, while testosterone had normalized months earlier. In the older testosterone-enanthate studies (Mauss 1975, Aribarg 1996), full suppression of spermatogenesis and its slow return were documented decades before cycles were common.
If children are a plan, the recovery panel needs a semen analysis alongside it, and a normal FSH is not a substitute. A single analysis at 4 to 6 weeks post-PCT will often still be low because of the 74-day spermatogenic cycle; the 3-month confirmation draw is the meaningful one. The fertility side of suppression is covered in fertility and suppression on steroids.
5 PCT Bloodwork Mistakes That Make the Results Meaningless
1. Testing during PCT. LH and FSH on clomiphene are the drug's effect, not the axis's. Draw 4 to 6 weeks after the last dose.
2. Ordering testosterone alone. Without LH and FSH there is no way to tell a recovering axis from a stalled one at the same testosterone value. This is the single most common panel error.
3. No pre-cycle baseline. 410 ng/dL is a full recovery for one man and half a recovery for another. Without the baseline you are comparing yourself to a population average.
4. Treating it as a hormone-only panel. HDL suppression outlasts the cycle, hematocrit stays high for weeks, and neither produces symptoms. Skipping the CBC and lipids because you feel fine defeats the purpose of objective monitoring.
5. Declaring recovery on one panel. A single 450 ng/dL is a data point. Two or three sequential panels, with LH and FSH stable above the lower limit and testosterone trending up, are a recovery. If nothing has moved by 3 to 4 months post-cycle, the next step is an endocrinologist, not another PCT.
PCT Bloodwork: Common Questions
What bloodwork should I get after PCT?
The core PCT bloodwork after therapy is total testosterone, LH and FSH, plus estradiol by LC-MS/MS, a CBC for hematocrit, a lipid panel, and liver enzymes if oral steroids were used. Add a semen analysis if fertility matters and prolactin if LH stays low. Draw it 4 to 6 weeks after the last PCT dose.
When should I get bloodwork after PCT?
Four to six weeks after the last dose of clomiphene or tamoxifen, so that the drugs have cleared and the result shows what the axis sustains on its own. A confirmation panel at about three months post-cycle is recommended, and a semen analysis is most meaningful at that point.
Should I get bloodwork before starting PCT?
Yes. A panel drawn after the esters have cleared and before the first PCT dose records how deep the suppression is, which is the only way to judge later whether PCT did anything. Testosterone will usually be very low and LH and FSH near zero; that is expected.
What LH and FSH levels mean recovery after a cycle?
With the PCT drugs cleared, LH rising into roughly 3 to 8 IU/L and FSH moving with it means the pituitary has re-engaged, even if testosterone is still below range. LH and FSH still near zero weeks after PCT means a stalled axis; LH and FSH above the normal range with low testosterone means the testes are not responding.
What testosterone level counts as recovered after PCT?
The pre-cycle baseline is the real target. As a rule of thumb, above about 400 ng/dL with LH present is a working recovery; below 300 ng/dL at 4 to 6 weeks post-PCT should be repeated, and below the harmonized lower limit of 264 ng/dL at 3 to 4 months post-cycle warrants an endocrinology referral.
Can bloodwork during PCT show recovery?
No. PCT bloodwork drawn while the drugs are on board measures the drugs. Clomiphene and tamoxifen raise LH and FSH for as long as they are taken, so a panel drawn during PCT measures the drug effect. It can confirm the drug is working, but it cannot show what the axis will do once the drug is gone.
Does testosterone recovery mean sperm has recovered?
No. In the HAARLEM cohort testosterone was back at baseline three months after the cycle while sperm count was still 61.7 million lower, and still reduced at the end of the one-year study. Pooled contraceptive data put the median sperm recovery at 3.4 months. Only a semen analysis answers the fertility question.
What if my bloodwork shows no recovery after PCT?
Repeat once under proper conditions, with prolactin and estradiol added. If testosterone is still low with absent or very high gonadotropins at 3 to 4 months post-cycle, see an endocrinologist with all the panels. A share of users, 11 to 27 percent in the cohorts, do not recover fully, and self-managed repeat PCT does not fix a primary testicular problem.
References
Related PCT Guides
Final Educational Note
This PCT bloodwork article discusses laboratory monitoring around post-cycle therapy for educational and harm-reduction purposes. It is not medical advice, does not describe PCT drug protocols, and does not replace interpretation of your results by a physician or endocrinologist. Reference ranges vary between laboratories; the numbers here are orientation, not cutoffs for self-treatment.
MuscleScience does not sell or supply any compound. For the wider series, start at the PCT hub and the bloodwork and health hub. Author names are pseudonyms; see the About page and Disclaimer.
